A living WHO guideline on drugs for covid-19

…, E Burhan, CS Calfee, M Cecconi, D Chanda… - 2022 - scholar.sun.ac.za
This living guideline by Arnav Agarwal and colleagues (BMJ 2020; 370: m3379, doi: 10.1136/bmj.
m3379) was last updated on 22 April 2022, but the infographic contained two dosing …

A living WHO guideline on drugs for covid-19

…, CS Calfee, M Cecconi, B Chacko, D Chanda… - bmj, 2020 - bmj.com
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published as …

Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled …

G Theron, L Zijenah, D Chanda, P Clowes, A Rachow… - The Lancet, 2014 - thelancet.com
Background The Xpert MTB/RIF test for tuberculosis is being rolled out in many countries, but
evidence is lacking regarding its implementation outside laboratories, ability to inform same…

[HTML][HTML] Antifungal combinations for treatment of cryptococcal meningitis in Africa

…, A Loyse, C Kouanfack, D Chanda… - … England Journal of …, 2018 - Mass Medical Soc
Background Cryptococcal meningitis accounts for more than 100,000 human immunodeficiency
virus (HIV)–related deaths per year. We tested two treatment strategies that could be …

[HTML][HTML] Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey

…, N Sinyange, N Kapata, PM Zulu, D Chanda… - The Lancet Global …, 2021 - thelancet.com
Background Between March and December, 2020, more than 20 000 laboratory-confirmed
cases of SARS-CoV-2 infection were reported in Zambia. However, the number of SARS-CoV…

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic …

JG Peter, LS Zijenah, D Chanda, P Clowes, M Lesosky… - The Lancet, 2016 - thelancet.com
Background HIV-associated tuberculosis is difficult to diagnose and results in high mortality.
Frequent extra-pulmonary presentation, inability to obtain sputum, and paucibacillary …

Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies

…, M Bates, N Kapata, T Nyirenda, D Chanda… - The Lancet …, 2015 - thelancet.com
WHO estimates that 9 million people developed active tuberculosis in 2013 and 1·5 million
people died from it. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) …

Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania …

S Mfinanga, D Chanda, SL Kivuyo, L Guinness… - The Lancet, 2015 - thelancet.com
Background Mortality in people in Africa with HIV infection starting antiretroviral therapy (ART)
is high, particularly in those with advanced disease. We assessed the effect of a short …

[HTML][HTML] Antimicrobial usage at a large teaching hospital in Lusaka, Zambia

…, A Herbert, S Fwoloshi, PM Zulu, D Chanda… - PLoS …, 2020 - journals.plos.org
Antimicrobial resistance is a growing global health concern. Antimicrobial stewardship (AMS)
curbs resistance rates by encouraging rational antimicrobial use. However, data on …

A living WHO guideline on drugs to prevent covid-19

…, E Burhan, M Cecconi, B Chacko, D Chanda… - bmj, 2021 - bmj.com
Clinical question What is the role of drugs in preventing covid-19? Why does this matter?
There is widespread interest in whether drug interventions can be used for the prevention of …